Evidence For Cannabidiol Modulation of Serotonergic Transmission in a Model of Osteoarthritis via in vivo PET Imaging and Behavioral Assessment

BACKGROUND: Preclinical studies indicate that cannabidiol (CBD), the primary nonaddictive component of cannabis, has a wide range of reported pharmacological effects such as analgesic and anxiolytic actions; however, the exact mechanisms of action for these effects have not been examined in chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yu-Shin, Wang, Jiacheng, Kumar, Vinay, Ciaccio, James, Dakhel, Sami, Tan, Cathy, Kim, Jonathan, Lee, Sabrina, Katz-Lichtenstein, Hilla, Gironda, Zakia, Mishkit, Orin, Mroz, Jakub, Jackson, Raul, Yoon, Grace, Gamallo-Lana, Begona, Klores, Molly, Mar, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576525/
https://www.ncbi.nlm.nih.gov/pubmed/37841504
http://dx.doi.org/10.23958/ijirms/vol07-i06/1418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576525/
https://www.ncbi.nlm.nih.gov/pubmed/37841504
http://dx.doi.org/10.23958/ijirms/vol07-i06/1418

Ejemplares similares